MYCO fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Mydecine Innovations Group, Inc. is a biotechnology company, which engages in the research, drug development, and clinical trials of psilocybin products. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
MYCO has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company